Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biomedical Big Data Training Program at UC Berkeley
Lifecourse cardiovascular risk, depression and cognition in black & white adults
Short-term Research Training Program for Minority Students
Mechanotransduction analysis in a microengineered lung-on-a-chip
Growth Control of Prostate Cancer Cells by Plant Phenols
Recently added grants:
Targeting Chemoreceptor Control of Breathing during Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
Understanding and targeting stress reactivity in women Veterans with alcohol misuse
CPT-SMART for Treatment of PTSD and Cigarette Smoking
Using Big-Data to Identify & Prevent Transmission of Carbapenem-Resistant Enterobacteriaceae within VHA
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-010
Application #
7191423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant